Tai Y-T, Fulciniti M, Hideshima T, Song W, Leiba M, Li X-F, Rumizen M, Burger P, Morrison A, Podar K, Chauhan D, Tassone P, Richardson P, Munshi NC, Ghobrial IM, Anderson KC. Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis. Blood. 2007;110(5):1656-1663
- PMID: 39231434
- PMCID: PMC11864212
- DOI: 10.1182/blood.2024026818
Tai Y-T, Fulciniti M, Hideshima T, Song W, Leiba M, Li X-F, Rumizen M, Burger P, Morrison A, Podar K, Chauhan D, Tassone P, Richardson P, Munshi NC, Ghobrial IM, Anderson KC. Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis. Blood. 2007;110(5):1656-1663
Abstract
This article has been retracted; please see Elsevier's Article Correction, Retraction and Removal Policy (Article withdrawal | Elsevier policy).This article has been retracted at the request of the Editors and authors.Within the paper, image issues were identified in Figures 1, 4, and 6. Images within these figures show duplication, modification, or unmarked splices.The authors state that these figures cannot be used to support the conclusions of the paper.Authors Tai, Fulciniti, Song, Li, Morrison, Chauhan, Tassone, Ghobrial, and Anderson approve the retraction. Authors Hideshima, Leiba, Rumizen, Burger, Podar, Richardson, and Munshi did not respond.
© 2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Retraction of
-
Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis.Blood. 2007 Sep 1;110(5):1656-63. doi: 10.1182/blood-2007-03-081240. Epub 2007 May 17. Blood. 2007. Retraction in: Blood. 2024 Oct 10;144(15):1648. doi: 10.1182/blood.2024026818. PMID: 17510321 Free PMC article. Retracted. Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources
